Alnylam Pharmaceuticals, Inc.

Sumitomo Mitsui Trust Group, Inc. ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/23/2026

Shares

327,763

Value ($000)

130,335

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/23/2026	130,335	0.1%	327,763	12/31/2025
2025 Q3	10/27/2025	143,390	0.1%	314,452	9/30/2025
2025 Q2	7/31/2025	95,721	0.1%	293,542	6/30/2025
2025 Q1	4/25/2025	78,704	0.1%	291,476	3/31/2025
2024 Q4	1/28/2025	67,464	0.0%	286,703	12/31/2024
2024 Q3	11/5/2024	76,525	0.1%	278,241	9/30/2024
2024 Q2	7/19/2024	67,298	0.0%	276,947	6/30/2024
2024 Q1	4/19/2024	43,489	0.0%	290,996	3/31/2024
2023 Q4	1/30/2024	56,519	0.0%	295,279	12/31/2023
2023 Q3	10/30/2023	52,546	0.0%	296,700	9/30/2023
2023 Q2	7/31/2023	56,722	0.0%	298,629	6/30/2023
2023 Q1	4/27/2023	68,303	0.1%	340,967	3/31/2023
2022 Q4	1/30/2023	80,082	0.1%	336,976	12/31/2022
2022 Q3	10/21/2022	67,791	0.1%	338,685	9/30/2022
2022 Q2	7/26/2022	49,274	0.0%	337,842	6/30/2022
2022 Q1	4/27/2022	52,701	0.0%	322,743	3/31/2022
2021 Q4	2/2/2022	55,021	0.0%	324,452	12/31/2021
2021 Q3	10/25/2021	62,793	0.0%	332,571	9/30/2021
2021 Q2	8/2/2021	58,979	0.0%	347,915	6/30/2021
2021 Q1	4/30/2021	52,295	0.0%	370,384	3/31/2021
2020 Q4	2/5/2021	49,572	0.0%	381,411	12/31/2020
2020 Q3	10/30/2020	64,456	0.0%	442,695	9/30/2020
2020 Q2	7/27/2020	82,800	0.1%	559,044	6/30/2020
2020 Q1	4/27/2020	79,457	0.1%	729,969	3/31/2020
2019 Q4	1/31/2020	51,024	0.0%	443,036	12/31/2019